Call to Action

We believe there should be a new global goal of gender-neutral HPV vaccination in every country by 2030.

1. HPV must be understood

HPV must be understood, and responded to, as a threat to the health of all sexes and genders.

2. Eliminate high-risk types

GNV should be viewed from the perspective of its potential to eliminate high-risk, oncogenic HPV types, thereby accelerating the elimination of not only cervical cancer but also all the cancers caused by HPV.

3. Make boys a primary target for vaccination

By 2028, global policymakers should have reviewed the issue of GNV with a view to recommending its implementation. WHO should make boys a primary target for HPV vaccination.

4. Gender-neutral vaccination

By 2030, all countries currently without an HPV vaccination programme should have introduced HPV vaccination on a gender-neutral basis while countries currently with a girls-only programme should have transitioned to GNV.

5. Health partnerships between countries

Health partnerships between countries with established GNV programmes and lower-income countries should be established along with capacity-building initiatives to support the wider implementation of GNV.

6. Focus on increasing vaccine uptake

A greater focus is needed on increasing vaccine uptake to at least 90% for all, a target most likely to be achieved through school-based vaccination programmes.

Endorse the Call to Action!

Does your organisation support global gender-neutral HPV vaccination? Are you interested in endorsing our Call to Action and would like to partner with us?

Please sign up to join the growing community of organisations worldwide who support this call.

Boys, Men and HPV: a call for global gender-neutral HPV vaccination

Boys, Men and HPV: a call for global gender-neutral HPV vaccination

A six-point plan from GAMH and NOMAN calling on WHO, health bodies and governments to achieve gender-neutral HPV vaccination worldwide by 2030.

Download now

We are proud to be endorsed by

67 organisations worldwide